AndroConnect: November 7th 2024

Join us on November 7th to hear about Fecundis, a company that has  a mission to transform fertility treatments, which are often lengthy, inefficient, and difficult for patients. Fecundis develops cutting-edge sperm-enhancing technologies rooted in a deep understanding of reproductive biology, aiming to improve the success rates of infertility treatments. Their solutions are designed to integrate seamlessly into clinical workflows, making fertility care not only more effective but also more patient-friendly.

Dr. Vassena is the co-founder and CEO of Fecundis. Previously, Dr. Vassena has been the global Scientific Director of the Eugin Group. She has more than 20 years of experience in the field of reproduction with more than 130 publications in peer reviewed international journals and book chapters. Currently, she serves on the Executive Committee of the Spanish Fertility Society and is an advisor to several companies in the fertility space.

You can find more information about Fecundis on: https://fecundis.com/

The Zoom link will be sent via newsletter days before the Webinar.